Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$139.73 - $157.03 $39.1 Million - $43.9 Million
-279,700 Reduced 37.9%
458,200 $70.2 Million
Q4 2023

Feb 14, 2024

BUY
$115.38 - $145.63 $20.4 Million - $25.7 Million
176,400 Added 31.42%
737,900 $105 Million
Q3 2023

Nov 14, 2023

BUY
$128.62 - $166.13 $36.8 Million - $47.5 Million
285,800 Added 103.66%
561,500 $73.6 Million
Q2 2023

Aug 14, 2023

SELL
$153.94 - $175.61 $16.6 Million - $18.9 Million
-107,600 Reduced 28.07%
275,700 $43.8 Million
Q1 2023

May 15, 2023

SELL
$139.79 - $158.24 $36.2 Million - $41 Million
-258,900 Reduced 40.31%
383,300 $60.7 Million
Q4 2022

Feb 14, 2023

SELL
$125.76 - $150.99 $57.5 Million - $69.1 Million
-457,600 Reduced 41.61%
642,200 $90.1 Million
Q3 2022

Nov 14, 2022

SELL
$128.39 - $149.74 $26.1 Million - $30.4 Million
-203,300 Reduced 15.6%
1,099,800 $141 Million

Others Institutions Holding CLX

About CLOROX CO


  • Ticker CLX
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 123,356,000
  • Market Cap $16.8B
  • Description
  • The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-S...
More about CLX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.